POLE and cancer: Specifically, the POLE p.S459F hotspot mutation was found in samples of endometrioid endometrial carcinoma from patients with synchronous endometrioid endometrial and ovarian carcinomas, which generally have a better prognosis compared with individual occurrences of these cancers independently [62].